Literature DB >> 1894871

Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty.

C A Nienaber1, R C Brunken, C T Sherman, L A Yeatman, S S Gambhir, J Krivokapich, L L Demer, O Ratib, J S Child, M E Phelps.   

Abstract

Although revascularization of hypoperfused but metabolically active human myocardium improves segmental function, the temporal relations among restoration of blood flow, normalization of tissue metabolism and recovery of segmental function have not been determined. To examine the effects of coronary angioplasty on 13 asynergic vascular territories in 12 patients, positron emission tomography and two-dimensional echocardiography were performed before and within 72 h of revascularization. Ten patients underwent late echocardiography (67 +/- 19 days) and eight underwent a late positron emission tomographic study (68 +/- 19 days). The extent and severity of abnormalities of wall motion, perfusion and glucose metabolism were expressed as wall motion scores, perfusion defect scores and perfusion-metabolism mismatch scores. Angioplasty significantly increased mean stenosis cross-sectional area (from 0.95 +/- 0.9 to 2.7 +/- 1.4 mm2) and mean cross-sectional luminal diameter (from 0.9 +/- 0.6 to 1.9 +/- 0.5 mm) (both p less than 0.001). Perfusion defect scores in dependent vascular territories improved early after angioplasty (from 116 +/- 166 to 31 +/- 51, p less than 0.002) with no further improvement on the late follow-up study. The mean perfusion-metabolism mismatch score decreased from 159 +/- 175 to 65 +/- 117 early after angioplasty (p less than 0.01) and to 26 +/- 29 at late follow-up (p less than 0.001 vs. before angioplasty; p = NS vs. early after angioplasty). However, absolute rates of glucose utilization remained elevated early after revascularization, normalizing only at late follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894871     DOI: 10.1016/0735-1097(91)90755-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

Review 1.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 2.  Recovery of myocardial function in the hibernating heart.

Authors:  C W Hamm
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 3.  Hibernating myocardium: a historical perspective.

Authors:  J F Tubau; S H Rahimtoola
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

4.  Imaging modalities for detection of myocardial viability.

Authors:  R Underwood
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

Review 5.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

Review 6.  Non-invasive assessment of residual viability in post-myocardial infarction patients. Role of nuclear techniques.

Authors:  O Parodi; P Marzullo; G Sambuceti; D Neglia; A Gimelli; A Giorgetti
Journal:  Int J Card Imaging       Date:  1993

Review 7.  The role of scintigraphic techniques in the evaluation of functional results of coronary bypass grafting and percutaneous transluminal coronary angioplasty.

Authors:  A F Kuijper; B L van Eck-Smit; M G Niemeyer; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Int J Card Imaging       Date:  1993

8.  Prospective evaluation of thallium-201 reinjection in single-vessel coronary patients undergoing coronary bypass surgery.

Authors:  J Mester; I Kósa; G Lupkovics; N Gruber; M Lázár; G Kovács; L Csernay
Journal:  Eur J Nucl Med       Date:  1993-03

Review 9.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

Review 10.  Myocardial viability: what do we need?

Authors:  H Schoeder; M Friedrich; H Topp
Journal:  Eur J Nucl Med       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.